Teva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital
The portfolio includes Ovaleap, Zoely, Seasonique, Colpotrophine, Actonel and additional products. Source: BioSpace
The portfolio includes Ovaleap, Zoely, Seasonique, Colpotrophine, Actonel and additional products. Source: BioSpace
Here is a look at a few important regulatory events scheduled for the month of February. Source: BioSpace
Only a week after launch, Partner Therapeutics acquired the global rights to Leukine from Sanofi. Source: BioSpace
Fitzgerald resigns four months after ex-HHS Secretary Price. Source: BioSpace
Celltrion are down more than 5 percent after the company announced it received a warning letter from the FDA after the regulatory agency inspected a company drug manufacturing facility. Source:…
Sluggish growth is the main driver for the decision.. Source: BioSpace
Vertex is keeping its promise of advancing triple combination treatments for patients with cystic fibrosis and investors are happy. Source: BioSpace
The company plans to initiate a Phase 2 clinical trial this year with AVR-RD-01 in Fabry disease. Source: BioSpace
Today STADA announced the appointment of Peter Goldschmidt as new CEO and chairman of the board. Source: BioSpace
Dr. Paul has been with the company for six years since its inception, initially as president of R&D, Source: BioSpace